We are live on ! Find out more
DRTS icon

Alpha Tau Medical
DRTS

23 hedge funds and large institutions have $3.65M invested in Alpha Tau Medical in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

15% more funds holding

Funds holding: 20 → 23 (+3)

8% more capital inflows, than outflows

Capital inflows: $1.28M | Capital outflows: $1.18M

0.04% more ownership

Funds ownership: 1.37% → 1.41% (+0.04%)

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HoyleCohen
HoyleCohen
California
+$986K
2
Levin Capital Strategies
Levin Capital Strategies
New York
+$238K
3
Advisory Services Network
Advisory Services Network
Georgia
+$44K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.7K
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.74K

Top Sellers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
-$1.18M

DRTS Hedge Fund Activity: Q3 2023 in Review

23 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q3 2023, worth a combined $3.65M — down 11% from $4.11M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new DRTS positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was HoyleCohen, opening a new position worth an estimated $986K. The largest seller was Citigroup, cutting an estimated $1.18M.

  • 23 institutional investors held Alpha Tau Medical (DRTS) as of Q3 2023, up from 20 in Q2 2023.
  • Funds reported $3.65M of Alpha Tau Medical stock for Q3 2023, down 11% quarter-over-quarter.
  • 3 funds opened new Alpha Tau Medical positions in Q3 2023 and 0 closed out, a net change of +3 holders.
  • The largest Alpha Tau Medical buyer in Q3 2023 was HoyleCohen, an estimated $986K added.
  • The largest Alpha Tau Medical seller in Q3 2023 was Citigroup, an estimated $1.18M sold.

Based on aggregated 13F filings for Q3 2023.